Skip to content

A study of the effects of fasting and supplementation on glucose and lipid metabolism

A study of the effects of fasting and supplementation on glucose and lipid metabolism - A study of the effects of fasting and supplementation on glucose and lipid metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050667
Enrollment
63
Registered
2023-03-24
Start date
2023-04-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Participation in a 3-night 4-day fasting program Then, take 3 supplements for 31 days. Take 3 supplements for 34 days. Non-intervention

Sponsors

Akasaka Family Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese who are 40 years old or under 64 years old 2) Persons who are healthy and do not have chronic physical or mental illnesses 3) Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 4) Persons with a BMI of 22 or higher 5) Persons who can come to the clinic on the designated day and undergo the examination 6) Persons who have been deemed suitable for participation in this study by the responsible physician.

Exclusion criteria

Exclusion criteria: 1) Persons who are currently suffering from some kind of disease and are judged by the investigator to need treatment 2) Persons with a history or current illness of severe disorders including liver, kidney, heart, lung, blood, digestive system, etc. 3) Persons with alcohol dependence or other mental disorders 4) Persons with a habit of taking medication for treatment of illness within the past month (excluding occasional use of medication for headache, menstrual pain, cold, etc.) 5) Persons who may develop seasonal allergy symptoms during the trial period, specific allergens include: Hanoki, Oobayashabushi, birch, sugi, hinoki, ragweed, mugwort, orchardgrass, and timothy grass 6) Persons who may experience allergic reactions to the ingredients in the test food, or those who may experience severe allergic reactions to other food or medication 7) Persons with severe anemia 8) Persons prone to contact dermatitis, those who have had it in the past, or those with sensitive fingertips 9) Persons who have a smoking habit 10) Women who are pregnant, nursing, planning to become pregnant during the trial period, or planning to become pregnant during the trial period 11) Persons who may change their lifestyle during the trial period (e.g., night shift work, long-term travel, etc.) 12) Persons who have habitually consumed functional food, health food, supplements containing ingredients of the test food within the past 3 months or plan to consume them during the trial period. 13) Persons who have received treatment requiring hospitalization within the past 6 months. 14) Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 15) Persons who are judged by the investigator to be inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Total cholesterol, LDL, HDL, triglycerides, oxidized LDL, adiponectin, glucose, glycoalbumin, HbA1c,insulin, HOMA-IR Measure at before and after intervention.

Secondary

MeasureTime frame
Telomere length, G-tail length, protein, albumin, AST, ALT, Ca, Mg, Fe, Cu, ferritin, zinc, EPA, DHA, EPA/AA ratio, DHA/AA ratio, (EPA+DHA)/AA ratio, CRP, IL-6, TNFalpha, Hb, Ht, MCV, MHC, MCHC, systolic blood pressure, diastolic blood pressure, OSA-MA sleep quality test, POMS stress test, heavy metal mineral test, urinary 8-OHdG, height, weight, BMI, lean body mass Measure at before and after intervention.

Countries

Japan

Contacts

Public ContactMitsuko Ito

Akasaka Family Clinic Clinic Director

info@afc.tokyo03-5562-8825

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026